The Valley Desk

NCT07284654 · Interventional trial

Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49

Overall registry status Completed

Phase 3

Conditions Pneumococcal Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov